<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mira Maximos</style></author><author><style face="normal" font="default" size="100%">Ryan Pelletier</style></author><author><style face="normal" font="default" size="100%">Sameer Elsayed</style></author><author><style face="normal" font="default" size="100%">Colleen J. Maxwell</style></author><author><style face="normal" font="default" size="100%">Sherilyn K. D. Houle</style></author><author><style face="normal" font="default" size="100%">Brie McConnell</style></author><author><style face="normal" font="default" size="100%">John‐Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">British Journal of Clinical Pharmacology</style></title><secondary-title><style face="normal" font="default" size="100%">A systematic review and meta‐analysis of interventions to delabel low‐risk penicillin allergies with consideration for sex and gender</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1111/bcp.16366</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mira Maximos</style></author><author><style face="normal" font="default" size="100%">Ryan Pelletier</style></author><author><style face="normal" font="default" size="100%">Sameer Elsayed</style></author><author><style face="normal" font="default" size="100%">Colleen J. Maxwell</style></author><author><style face="normal" font="default" size="100%">Sherilyn K. D. Houle</style></author><author><style face="normal" font="default" size="100%">Brie McConnell</style></author><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hospital Pharmacy</style></title><secondary-title><style face="normal" font="default" size="100%">Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-Analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1177/00185787251337626</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author><author><style face="normal" font="default" size="100%">Baiju Shah</style></author><author><style face="normal" font="default" size="100%">David N. Juurlink</style></author><author><style face="normal" font="default" size="100%">Alexander Kopp</style></author><author><style face="normal" font="default" size="100%">Lena Nguyen</style></author><author><style face="normal" font="default" size="100%">J Michael Paterson</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of General Internal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Risk of Hospital Presentation with Hypoglycemia Among Users of Beta-blockers with Diabetes: Population-Based Nested Case–Control Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1007/s11606-025-09467-w</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Irene Jiayu Guo</style></author><author><style face="normal" font="default" size="100%">Mira Maximos</style></author><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">CMI Communications</style></title><secondary-title><style face="normal" font="default" size="100%">Examining hypoglycemia risk with systemic fluoroquinolone use: A systematic review and meta-analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2024</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1016/j.cmicom.2024.105038</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wajd Alkabbani</style></author><author><style face="normal" font="default" size="100%">Colleen J. Maxwell</style></author><author><style face="normal" font="default" size="100%">Ruth Ann Marrie</style></author><author><style face="normal" font="default" size="100%">Suzanne L. Tyas</style></author><author><style face="normal" font="default" size="100%">Iliana C. Lega</style></author><author><style face="normal" font="default" size="100%">John‐Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes, Obesity and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2024</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1111/dom.15385</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Darren Lau</style></author><author><style face="normal" font="default" size="100%">John‐Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes, Obesity and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Suicidality among users of glucagon‐like peptide‐1 receptor agonists: An emerging signal?</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2024</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1111/dom.15459</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anna Bien</style></author><author><style face="normal" font="default" size="100%">Joey Champigny</style></author><author><style face="normal" font="default" size="100%">Caitlin Carter</style></author><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">OSF Registries</style></title><secondary-title><style face="normal" font="default" size="100%">Visualizations for communicating drug benefits and harms: A scoping review protocol</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2024</style></year></dates><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">British Journal of Clinical Pharmacology</style></title><secondary-title><style face="normal" font="default" size="100%">Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85124712639&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Journal of Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021)</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85143981743&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Maxwell, C.J.</style></author><author><style face="normal" font="default" size="100%">Marrie, R.A.</style></author><author><style face="normal" font="default" size="100%">Tyas, S.L.</style></author><author><style face="normal" font="default" size="100%">Lega, I.C.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes Care</style></title><secondary-title><style face="normal" font="default" size="100%">Associations of Mid-and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85147047452&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Maxwell, C.J.</style></author><author><style face="normal" font="default" size="100%">Marrie, R.A.</style></author><author><style face="normal" font="default" size="100%">Tyas, S.L.</style></author><author><style face="normal" font="default" size="100%">Lega, I.C.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes Care</style></title><secondary-title><style face="normal" font="default" size="100%">Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85165521395&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Shah, B.R.</style></author><author><style face="normal" font="default" size="100%">Zongo, A.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, M.W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes, Obesity and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85167588605&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85152556353&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Maxwell, C.J.</style></author><author><style face="normal" font="default" size="100%">Marrie, R.A.</style></author><author><style face="normal" font="default" size="100%">Tyas, S.L.</style></author><author><style face="normal" font="default" size="100%">Lega, I.C.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">International Journal of Epidemiology</style></title><secondary-title><style face="normal" font="default" size="100%">Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85147424628&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of Pharmaceutical Health Services Research</style></title><secondary-title><style face="normal" font="default" size="100%">Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85163707017&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bradley Grightmire</style></author><author><style face="normal" font="default" size="100%">Wajd Alkabbani</style></author><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">American Journal of Medicine Open</style></title><secondary-title><style face="normal" font="default" size="100%">Peak performance: Putting type 1 diabetes management recommendations for athletes to the test</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1016/j.ajmo.2022.100011</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, Joseph Emil</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Farrell, Jamie</style></author><author><style face="normal" font="default" size="100%">Gao, Zhiwei</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Association between Inhaled beta(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study</style></title><secondary-title><style face="normal" font="default" size="100%">INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">1205-1217</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Alkabbani, Wajd</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Authors' Reply to Noguchi's comment on: ``Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data''</style></title><secondary-title><style face="normal" font="default" size="100%">DRUG SAFETY</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">JUL</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">45</style></volume><pages><style face="normal" font="default" size="100%">813-814</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Zongo, A.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, J.K.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Shah, B.R.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, M.W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Journal of Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85129507933&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Seng Bong Ing, N.</style></author><author><style face="normal" font="default" size="100%">Amoud, R.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, M.W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Journal of Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">Trends and Determinants of Self-reported Aspirin Use Among Patients With Diabetes Stratified by Presence and Risk of Cardiovascular Diseases: A Repeated Pan-Canadian Cross-sectional Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85129977549&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, J.K.</style></author><author><style face="normal" font="default" size="100%">Shah, B.R.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, M.W.</style></author><author><style face="normal" font="default" size="100%">Zongo, A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85120915534&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Zongo, A.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, J.K.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Shah, B.R.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, M.W.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetic Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85129462097&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.”</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85132201172&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Pelletier, R.</style></author><author><style face="normal" font="default" size="100%">Beazely, M.A.</style></author><author><style face="normal" font="default" size="100%">Labib, Y.</style></author><author><style face="normal" font="default" size="100%">Quan, B.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85125655701&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, Wajd</style></author><author><style face="normal" font="default" size="100%">Pelletier, Ryan</style></author><author><style face="normal" font="default" size="100%">Beazely, Michael A.</style></author><author><style face="normal" font="default" size="100%">Labib, Youssef</style></author><author><style face="normal" font="default" size="100%">Quan, Breanna</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data</style></title><secondary-title><style face="normal" font="default" size="100%">DRUG SAFETY</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">MAR</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">45</style></volume><pages><style face="normal" font="default" size="100%">287-295</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, Wajd</style></author><author><style face="normal" font="default" size="100%">Zongo, Arsene</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, Jasjeet K.</style></author><author><style face="normal" font="default" size="100%">Eurich, Dean T.</style></author><author><style face="normal" font="default" size="100%">Shah, Baiju R.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, Mhd Wasem</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">DIABETIC MEDICINE</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">AUG</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">8</style></number><volume><style face="normal" font="default" size="100%">39</style></volume><pages><style face="normal" font="default" size="100%">e14858</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, J.E.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Gao, Z.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">International Journal of COPD</style></title><secondary-title><style face="normal" font="default" size="100%">Association between Inhaled β&lt;sub&gt;2&lt;/sub&gt;-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85131104214&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, J.E.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Gao, Z.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Respiratory Research</style></title><secondary-title><style face="normal" font="default" size="100%">Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85144299296&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, Wajd</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Eurich, Dean T.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, Jasjeet K.</style></author><author><style face="normal" font="default" size="100%">Shah, Baiju R.</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, Mhd Wasem</style></author><author><style face="normal" font="default" size="100%">Zongo, Arsene</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs</style></title><secondary-title><style face="normal" font="default" size="100%">DIABETES &amp; METABOLISM</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">MAR</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">48</style></volume><pages><style face="normal" font="default" size="100%">101305</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pelletier, Ryan</style></author><author><style face="normal" font="default" size="100%">Nagge, Jeff</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Variation in bleeding risk estimates among online calculators Cross-sectional study of apps used by and for patients with atrial fibrillation</style></title><secondary-title><style face="normal" font="default" size="100%">CANADIAN FAMILY PHYSICIAN</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">APR 1</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">68</style></volume><pages><style face="normal" font="default" size="100%">E127-E135</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Giovannini-Green, Z.E.M.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Barrett, B.</style></author><author><style face="normal" font="default" size="100%">Gao, Z.</style></author><author><style face="normal" font="default" size="100%">Stuckless, S.</style></author><author><style face="normal" font="default" size="100%">Parfrey, P.S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Pharmacists Journal</style></title><secondary-title><style face="normal" font="default" size="100%">Variation and appropriateness of antipsychotic use in long-term care facilities across Newfoundland and Labrador</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85104822147&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, J.E.</style></author><author><style face="normal" font="default" size="100%">Gorgui, J.</style></author><author><style face="normal" font="default" size="100%">Acheampong, L.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Gao, Z.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of Asthma</style></title><secondary-title><style face="normal" font="default" size="100%">Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85075145584&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkabbani, W</style></author><author><style face="normal" font="default" size="100%">Gamble, JM</style></author><author><style face="normal" font="default" size="100%">Eurich, DT</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandu, J</style></author><author><style face="normal" font="default" size="100%">Shah, BR</style></author><author><style face="normal" font="default" size="100%">Alsabbagh, W</style></author><author><style face="normal" font="default" size="100%">Zongo, A</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Risk of hospitalization and death associated with Sodium Glucose Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs.</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes and Metabolism</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pelletier, R.</style></author><author><style face="normal" font="default" size="100%">Ng, K.</style></author><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Labib, Y.</style></author><author><style face="normal" font="default" size="100%">Mourad, N.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Therapeutic Advances in Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85099858370&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nguyen, H.V.</style></author><author><style face="normal" font="default" size="100%">Bornstein, S.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Mathews, M.</style></author><author><style face="normal" font="default" size="100%">Bishop, L.</style></author><author><style face="normal" font="default" size="100%">Mital, S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMC Public Health</style></title><secondary-title><style face="normal" font="default" size="100%">Too young for Cannabis? Choice of minimum legal age for legalized non-medical Cannabis in Canada</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85084964523&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Donnan, J.R.</style></author><author><style face="normal" font="default" size="100%">Johnston, K.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Marra, C.A.</style></author><author><style face="normal" font="default" size="100%">Aubrey-Bassler, K.</style></author><author><style face="normal" font="default" size="100%">Najafzadeh, M.</style></author><author><style face="normal" font="default" size="100%">Nguyen, H.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Journal of Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85068840292&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pelletier, R.</style></author><author><style face="normal" font="default" size="100%">Ng, K.</style></author><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author><author><style face="normal" font="default" size="100%">Labib, Y.</style></author><author><style face="normal" font="default" size="100%">Mourad, N.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Endocrinology, Diabetes and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85084999654&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, J.E.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Gao, Z.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">International Journal of COPD</style></title><secondary-title><style face="normal" font="default" size="100%">Gender differences in inhaled pharmacotherapy utilization in patients with obstructive airway diseases (OADS): A population-based study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85092135919&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alwashmi, M.F.</style></author><author><style face="normal" font="default" size="100%">Fitzpatrick, B.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Davis, E.</style></author><author><style face="normal" font="default" size="100%">van Nguyen, H.</style></author><author><style face="normal" font="default" size="100%">Farrell, G.</style></author><author><style face="normal" font="default" size="100%">Hawboldt, J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">JMIR mHealth and uHealth</style></title><secondary-title><style face="normal" font="default" size="100%">Perceptions of patients regarding mobile health interventions for the management of chronic obstructive pulmonary disease: Mixed methods study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85088678572&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hall, J.J.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Nagy, D.</style></author><author><style face="normal" font="default" size="100%">Tjosvold, L.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of General Internal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85081924061&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.M.</style></author><author><style face="normal" font="default" size="100%">Traynor, R.L.</style></author><author><style face="normal" font="default" size="100%">Gruzd, A.</style></author><author><style face="normal" font="default" size="100%">Mai, P.</style></author><author><style face="normal" font="default" size="100%">Dormuth, C.R.</style></author><author><style face="normal" font="default" size="100%">Sketris, I.S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacoepidemiology and Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alwashmi, M.F.</style></author><author><style face="normal" font="default" size="100%">Fitzpatrick, B.</style></author><author><style face="normal" font="default" size="100%">Davis, E.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Hawboldt, J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Therapeutic Advances in Respiratory Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85090365197&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, J.E.</style></author><author><style face="normal" font="default" size="100%">Badejo, O.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Wright, M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Jackson, B.</style></author><author><style face="normal" font="default" size="100%">Sultana, K.</style></author><author><style face="normal" font="default" size="100%">Hashmi, M.</style></author><author><style face="normal" font="default" size="100%">Gao, Z.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMJ Open</style></title><secondary-title><style face="normal" font="default" size="100%">Validated methods to identify patients with asthma-COPD overlap in healthcare databases: A systematic review protocol</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85062922942&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Donnan, J.R.</style></author><author><style face="normal" font="default" size="100%">Grandy, C.A.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Marra, C.A.</style></author><author><style face="normal" font="default" size="100%">Aubrey-Bassler, K.</style></author><author><style face="normal" font="default" size="100%">Johnston, K.</style></author><author><style face="normal" font="default" size="100%">Swab, M.</style></author><author><style face="normal" font="default" size="100%">Hache, J.</style></author><author><style face="normal" font="default" size="100%">Curnew, D.</style></author><author><style face="normal" font="default" size="100%">Nguyen, H.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMJ Open</style></title><secondary-title><style face="normal" font="default" size="100%">Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: A systematic review and meta-analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85061042887&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amegadzie, Joseph Emil</style></author><author><style face="normal" font="default" size="100%">Gorgui, Jessica</style></author><author><style face="normal" font="default" size="100%">Acheampong, Lily</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Farrell, Jamie</style></author><author><style face="normal" font="default" size="100%">Gao, Zhiwei</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis</style></title><secondary-title><style face="normal" font="default" size="100%">J Asthma</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J Asthma</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2019 Nov 12</style></date></pub-dates></dates><pages><style face="normal" font="default" size="100%">1-16</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt; To determine the safety and effectiveness of current pharmacotherapies consisting of long-acting beta-agonist (LABA) and/or inhaled corticosteroids (ICS) in patients with asthma-COPD overlap. A systematic search was conducted using the PubMed, EMBASE, and Web of Science databases up to June 2018. Only studies comparing the safety and effectiveness of LABA and/or ICS in patients with asthma-COPD overlap were included. A meta-analysis was performed to calculate risk ratio (RR) and 95% confidence interval (CI) using Inverse Variance Random-effects model. From a total of 3382 articles retrieved, three randomized controlled trials (RCTs), six cohort studies (CS), one nested case control study fulfilled the inclusion criteria for three independent meta-analyses representing 181,603 participants. Three CS results show LABA was associated with decreased risk of myocardial infarction (combined RR: 0.80, 95% CI 0.74-0.87) versus non-LABA use; ICS/LABA was associated with a lower risk of death or hospitalization (combined RR: 0.82, 95% CI 0.75-0.90) compared to no use. Results from RCTs, no clear difference in lung function decline in FEV was found (combined mean difference: 0.08, 95% CI 0.15-0.32) in patients receiving ICS and/or LABA compared to placebo. However, due to lack of data, exacerbations, fractures and nontuberculous mycobacterial pulmonary disease outcomes were not meta-analyzed. Among patients with asthma-COPD overlap, LABA is associated with decreased risk of myocardial infarction; and the combination therapy of ICS/LABA appears to reduce the risk of death or hospitalization. More studies of quality data and larger number of patients are needed. PROSPERO (CRD42018090863).&lt;/p&gt;</style></abstract><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/31668101?dopt=Abstract</style></custom1></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shakeri, Ahmad</style></author><author><style face="normal" font="default" size="100%">Dolovich, Lisa</style></author><author><style face="normal" font="default" size="100%">MacCallum, Lori</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Zhou, Limei</style></author><author><style face="normal" font="default" size="100%">Cadarette, Suzanne M</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Impact of the 2016 Policy Change on the Delivery of MedsCheck Services in Ontario: An Interrupted Time-Series Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacy (Basel)</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Pharmacy (Basel)</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2019 Aug 12</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;MedsCheck (MC) is an annual medication review service delivered by community pharmacists and funded by the government of Ontario since 2007 for residents taking three or more medications for chronic conditions. In 2010, MC was expanded to include patients with diabetes (MCD), home-bound patients (MCH), and residents of long-term care homes (MCLTC). The Ontario government introduced an abrupt policy change effective 1 October 2016 that added several components to all MC services, especially those completed in the community. We used an interrupted time series design to examine the impact of the policy change (24 months pre- and post-intervention) on the monthly number of MedsCheck services delivered. Immediate declines in all services were identified, especially in the community (47%-64% drop MC, 71%-83% drop MCD, 55% drop MCH, and 9%-14% drop MCLTC). Gradual increases were seen over 24 months post-policy change, yet remained 21%-76% lower than predicted for MedsCheck services delivered in the community, especially for MCD. In contrast, MCLTC services were similar or exceeded predicted values by September 2018 (from 5.1% decrease to 3.5% increase). A more effective implementation of health policy changes is needed to ensure the feasibility and sustainability of professional community pharmacy services.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/31409033?dopt=Abstract</style></custom1></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alwashmi, M.F.</style></author><author><style face="normal" font="default" size="100%">Fitzpatrick, B.</style></author><author><style face="normal" font="default" size="100%">Davis, E.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Hawboldt, J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">JMIR mHealth and uHealth</style></title><secondary-title><style face="normal" font="default" size="100%">Perceptions of health care providers regarding a mobile health intervention to manage chronic obstructive pulmonary disease: Qualitative study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85070540885&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alwashmi, Meshari F</style></author><author><style face="normal" font="default" size="100%">Fitzpatrick, Beverly</style></author><author><style face="normal" font="default" size="100%">Davis, Erin</style></author><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Farrell, Jamie</style></author><author><style face="normal" font="default" size="100%">Hawboldt, John</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study</style></title><secondary-title><style face="normal" font="default" size="100%">JMIR Mhealth Uhealth</style></secondary-title><alt-title><style face="normal" font="default" size="100%">JMIR Mhealth Uhealth</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Disease Management</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Focus Groups</style></keyword><keyword><style  face="normal" font="default" size="100%">Health Personnel</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Interviews as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style  face="normal" font="default" size="100%">Newfoundland and Labrador</style></keyword><keyword><style  face="normal" font="default" size="100%">Perception</style></keyword><keyword><style  face="normal" font="default" size="100%">Pulmonary Disease, Chronic Obstructive</style></keyword><keyword><style  face="normal" font="default" size="100%">Qualitative Research</style></keyword><keyword><style  face="normal" font="default" size="100%">Telemedicine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2019 06 10</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">e13950</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;b&gt;BACKGROUND: &lt;/b&gt;Using a mobile health (mHealth) intervention, consisting of a smartphone and compatible medical device, has the potential to enhance chronic obstructive pulmonary disease (COPD) treatment outcomes while mitigating health care costs.&lt;/p&gt;&lt;p&gt;&lt;b&gt;OBJECTIVE: &lt;/b&gt;The aim of this study was to explore the potential facilitators and barriers among health care providers (HCPs) regarding the use of mHealth interventions for COPD management.&lt;/p&gt;&lt;p&gt;&lt;b&gt;METHODS: &lt;/b&gt;This was a qualitative study. Semistructured individual interviews were conducted with HCPs, including nurses, pharmacists, and physicians who work directly with patients with COPD. A flexible prompts guide was used to facilitate discussions. Interview topics included the following: demographics, mHealth usage, perceptions toward challenges of mHealth adoption, factors facilitating mHealth adoption, and preferences regarding features of the mHealth intervention for COPD management. Interviews were conversational in nature, and items were not asked verbatim or in the order presented. The interviews were transcribed verbatim and compared against the digital recordings to ensure the accuracy of the content. After creating a codebook for analysis, 2 researchers independently coded the remaining interview data using pattern coding. They discussed commonalities and differences in coding until a consensus was reached.&lt;/p&gt;&lt;p&gt;&lt;b&gt;RESULTS: &lt;/b&gt;A total of 30 nurses, physicians, and pharmacists participated. The main facilitators to mHealth adoption are possible health benefits for patients, ease of use, educating patients and their HCPs, credibility, and reducing cost to the health care system. Alternatively, the barriers to adoption are technical issues, privacy and confidentiality issues, lack of awareness, potential limited uptake from the elderly, potential limited connection between patients and HCPs, and finances.&lt;/p&gt;&lt;p&gt;&lt;b&gt;CONCLUSIONS: &lt;/b&gt;It is important to understand the perceptions of HCPs regarding the adoption of innovative mHealth interventions for COPD management. This study identifies some potential facilitators and barriers that may inform the successful development and implementation of mHealth interventions for COPD management.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/31199330?dopt=Abstract</style></custom1></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abu-Ashour, W.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Valcour, J.E.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMC Infectious Diseases</style></title><secondary-title><style face="normal" font="default" size="100%">Diabetes and the occurrence of infection in primary care: A matched cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85041391565&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMJ open</style></title><secondary-title><style face="normal" font="default" size="100%">Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85054779701&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Donnan, J.R.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes Research and Clinical Practice</style></title><secondary-title><style face="normal" font="default" size="100%">The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85039789313&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">Dose response of sodium glucose cotransporter-2 inhibitors in relation to urinary tract infections: a systematic review and network meta-analysis of randomized controlled trials</style></title><secondary-title><style face="normal" font="default" size="100%">CMAJ Open</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://cmajopen.ca/content/6/4/E594.full</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of General Internal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85053375968&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Grandy, C.A.</style></author><author><style face="normal" font="default" size="100%">Donnan, J.R.</style></author><author><style face="normal" font="default" size="100%">Peddle, J.T.</style></author><author><style face="normal" font="default" size="100%">Romme, K.</style></author><author><style face="normal" font="default" size="100%">Kim, S.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of the American Medical Informatics Association</style></title><secondary-title><style face="normal" font="default" size="100%">A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85055131397&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.M.</style></author><author><style face="normal" font="default" size="100%">Traynor, R.L.</style></author><author><style face="normal" font="default" size="100%">Gruzd, A.</style></author><author><style face="normal" font="default" size="100%">Mai, P.</style></author><author><style face="normal" font="default" size="100%">Dormuth, C.R.</style></author><author><style face="normal" font="default" size="100%">Sketris, I.S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacoepidemiology and Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Donnan, J.R.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Scientific Reports</style></title><secondary-title><style face="normal" font="default" size="100%">Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85054774677&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abu-Ashour, W.</style></author><author><style face="normal" font="default" size="100%">Twells, L.</style></author><author><style face="normal" font="default" size="100%">Valcour, J.</style></author><author><style face="normal" font="default" size="100%">Randell, A.</style></author><author><style face="normal" font="default" size="100%">Donnan, J.</style></author><author><style face="normal" font="default" size="100%">Howse, P.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMJ Open Diabetes Research and Care</style></title><secondary-title><style face="normal" font="default" size="100%">The association between diabetes mellitus and incident infections: A systematic review and meta-analysis of observational studies</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85020049309&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abu-Ashour, W.</style></author><author><style face="normal" font="default" size="100%">Chibrikova, L.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetic Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anand, K.</style></author><author><style face="normal" font="default" size="100%">Sketris, I.</style></author><author><style face="normal" font="default" size="100%">Zhang, Y.</style></author><author><style face="normal" font="default" size="100%">Levy, A.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drugs - Real World Outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85047232099&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Chibrikov, E.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Young, S.W.</style></author><author><style face="normal" font="default" size="100%">MacDonald, D.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Lancet Diabetes and Endocrinology</style></title><secondary-title><style face="normal" font="default" size="100%">Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85006721048&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Howse, P.M.</style></author><author><style face="normal" font="default" size="100%">Chibrikova, L.N.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Barrett, B.J.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">American Journal of Kidney Diseases</style></title><secondary-title><style face="normal" font="default" size="100%">Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84994874856&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abu-Ashour, W.</style></author><author><style face="normal" font="default" size="100%">Chibrikova, L.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetic Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Factors associated with early insulin initiation in Type 2 diabetes: A Canadian cross-sectional study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alwashmi, M.</style></author><author><style face="normal" font="default" size="100%">Hawboldt, J.</style></author><author><style face="normal" font="default" size="100%">Davis, E.</style></author><author><style face="normal" font="default" size="100%">Marra, C.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Ashour, W.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">JMIR mHealth and uHealth</style></title><secondary-title><style face="normal" font="default" size="100%">The effect of smartphone interventions on patients with chronic obstructive pulmonary disease exacerbations: A systematic review and meta-analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85019981382&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author><author><style face="normal" font="default" size="100%">Sonia Butalia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Medical Practice Variations</style></title><secondary-title><style face="normal" font="default" size="100%">Medical Practice Variations in Diabetes Mellitus</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Thomas, J.M.</style></author><author><style face="normal" font="default" size="100%">Twells, L.K.</style></author><author><style face="normal" font="default" size="100%">Midodzi, W.K.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Medicine (United States)</style></title><secondary-title><style face="normal" font="default" size="100%">Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84978686237&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Davis, E.</style></author><author><style face="normal" font="default" size="100%">Marra, C.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Farrell, J.</style></author><author><style face="normal" font="default" size="100%">Lockyer, J.</style></author><author><style face="normal" font="default" size="100%">FitzGerald, J.M.</style></author><author><style face="normal" font="default" size="100%">Abu-Ashour, W.</style></author><author><style face="normal" font="default" size="100%">Gillis, C.</style></author><author><style face="normal" font="default" size="100%">Hawboldt, J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Trials</style></title><secondary-title><style face="normal" font="default" size="100%">Effectiveness of a pharmacist-driven intervention in COPD (EPIC): Study protocol for a randomized controlled trial</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84992108858&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Price, H.I.</style></author><author><style face="normal" font="default" size="100%">Agnew, M.D.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">BMJ Open</style></title><secondary-title><style face="normal" font="default" size="100%">Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: A systematic review</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84926434235&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">McAlister, F.A.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Therapeutics</style></title><secondary-title><style face="normal" font="default" size="100%">Limited Impact of Drug Exposure Misclassification from Non-Benefit Thiazolidinedione Drug Use on Mortality and Hospitalizations from Saskatchewan, Canada: A Cohort Study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84939996306&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Clarke, A.</style></author><author><style face="normal" font="default" size="100%">Myers, K.J.</style></author><author><style face="normal" font="default" size="100%">Agnew, M.D.</style></author><author><style face="normal" font="default" size="100%">Hatch, K.</style></author><author><style face="normal" font="default" size="100%">Snow, M.M.</style></author><author><style face="normal" font="default" size="100%">Davis, E.M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes, Obesity and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Incretin-based medications for type 2 diabetes: An overview of reviews</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84931957090&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Journal of Hospital Pharmacy</style></title><secondary-title><style face="normal" font="default" size="100%">An introduction to the fundamentals of cohort and case-control studies</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84928803939&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abdelmoneim, A.S.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.M.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">Seubert, J.M.</style></author><author><style face="normal" font="default" size="100%">Qiu, W.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes, Obesity and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84890569821&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">McAlister, F.A.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Medical Care</style></title><secondary-title><style face="normal" font="default" size="100%">Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: Controlled time-series analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84890441981&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Hall, J.J.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author><author><style face="normal" font="default" size="100%">Sadowski, C.A.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Therapeutics and Clinical Risk Management</style></title><secondary-title><style face="normal" font="default" size="100%">Medication transitions and polypharmacy in older adults following acute care</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84896942611&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abdelmoneim, A.S.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Canadian Journal of Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">Use patterns of antidiabetic regimens by patients with type2 diabetes</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84889564451&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Asadi, L.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.M.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, J.K.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Microbiology and Infection</style></title><secondary-title><style face="normal" font="default" size="100%">Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: Prospective cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84874315562&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">McAlister, F.A.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacoepidemiology and Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84877605478&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Boussageon, R.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Gueyffier, F.</style></author><author><style face="normal" font="default" size="100%">Cornu, C.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Therapie</style></title><secondary-title><style face="normal" font="default" size="100%">Clinically relevant efficacy of insulin therapy in patients with type 2 diabetes</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84891513444&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Boussageon, R.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Gueyffier, F.</style></author><author><style face="normal" font="default" size="100%">Cornu, C.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Therapie</style></title><secondary-title><style face="normal" font="default" size="100%">Clinically relevant efficacy of insulin therapy in patients with type 2 diabetes,Efficacité cliniquement pertinente de l’insulinothérapie chez les patients diabétiques de Type 2</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84891513444&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">MacIntyre, E.J.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, J.K.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">American Journal of Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Stress hyperglycemia and newly diagnosed diabetes in 2124 patients hospitalized with pneumonia</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84866494318&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">McAlister, F.A.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Therapeutics</style></title><secondary-title><style face="normal" font="default" size="100%">Restrictive Drug Coverage Policies can Induce Substantial Drug Exposure Misclassification in Pharmacoepidemiologic Studies</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84862127955&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Hoang, H.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Jindal, K.K.</style></author><author><style face="normal" font="default" size="100%">Senior, P.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of Primary Care and Community Health</style></title><secondary-title><style face="normal" font="default" size="100%">Patient-Level Evaluation of Community-Based, Multifactorial Intervention to Prevent Diabetic Nephropathy in Northern Alberta, Canada</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84926525003&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Asadi, L.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Minhas-Sandhu, J.K.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Respiratory Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Guideline adherence and macrolides reduced mortality in outpatients with pneumonia</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84855891949&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">McAlister, F.A.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Value in Health</style></title><secondary-title><style face="normal" font="default" size="100%">Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: A simulation cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-84862908093&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Ezekowitz, J.A.</style></author><author><style face="normal" font="default" size="100%">Kaul, P.</style></author><author><style face="normal" font="default" size="100%">Quan, H.</style></author><author><style face="normal" font="default" size="100%">McAlister, F.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Circulation: Heart Failure</style></title><secondary-title><style face="normal" font="default" size="100%">Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-79960611317&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Senthilselvan, A.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></title><secondary-title><style face="normal" font="default" size="100%">Oxygen saturations less than 92% are associated with major adverse events in outpatients with pneumonia: A population-based cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-79951830502&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Weir, D.L.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">CMAJ</style></title><secondary-title><style face="normal" font="default" size="100%">Analysis of drug coverage before and after the implementation of Canada's Common Drug Review</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-81855173449&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Mereu, L.</style></author><author><style face="normal" font="default" size="100%">Chambers, T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Journal of General Internal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: A meta-analysis</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-80755153633&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">American Journal of Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Admission Hypoglycemia and Increased Mortality in Patients Hospitalized with Pneumonia</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-77952978579&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Sattar, N.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Annals of Internal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Review: Statin use increases risk for diabetes</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-77954890761&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">John-Michael Gamble</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Annals of Internal Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Review: Statin use increases risk for diabetes</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes, Obesity and Metabolism</style></title><secondary-title><style face="normal" font="default" size="100%">Insulin use and increased risk of mortality in type 2 diabetes: A cohort study</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-73349095732&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.M.</style></author><author><style face="normal" font="default" size="100%">Marrie, T.J.</style></author><author><style face="normal" font="default" size="100%">Majumdar, S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetologia</style></title><secondary-title><style face="normal" font="default" size="100%">Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-77949264220&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Healthcare Policy</style></title><secondary-title><style face="normal" font="default" size="100%">A comparison of drug coverage in Alberta before and after the introduction of the national common drug review process</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-79851495266&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eurich, D.T.</style></author><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Simpson, S.H.</style></author><author><style face="normal" font="default" size="100%">Johnson, J.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes Care</style></title><secondary-title><style face="normal" font="default" size="100%">The darkening cloud of diabetes do Trends in cardiovascular risk management provide a silver lining?</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-59249095558&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>